Ultromics granted FDA Breakthrough Device Status
Ultromics has gained FDA Breakthrough Device Designation for its AI-powered EchoGo Amyloidosis platform, which is speeding up diagnosis.
Back to Top
Ultromics has gained FDA Breakthrough Device Designation for its AI-powered EchoGo Amyloidosis platform, which is speeding up diagnosis.
NHS Golden Jubilee has carried out the second highest number of ROSA procedures across the UK, after reaching a landmark 100 orthopaedic joint replacements.
Jordan Sollof is joined by Ling Lee, a GP and digital trailblazer fellow in Derby, to discuss her experience as a Shuri Network Bursary holder.
Following a successful trial in its radiology department, Sunderland Royal Hospital has now rolled out digital portering task management software.
Accurx Self-Book, which helps GPs schedule and book appointments could save Ā£123.1 million over five years if scaled up nationally, an evaluation found.
A randomised control study has shown that using the Healum planning software and app significantly improves health outcomes for Type 2 diabetes patients.
A decades-long partnership between Agilio Software and NICE has been extended for at least three more years, with Agilio providing trusted clinical content.
Disruptive digital health start-ups will feature across Rewired 2020, bringing them together with many of
Current IT systems ācannot support the safe running of screening programmes”, Professor Sir Mike Richards
Kinnear will leave his role in March 2020, telling Digital Health News it had been
New digital therapy programmes have been developed through a partnership between Berkshire Healthcare NHS Foundation
Three industries, genomics; digital health; and early diagnosis be critical to the UK continuing to